EMEA-000917-PIP02-11
Key facts
| Invented name |
Lumigan
|
| Active substance |
bimatoprost
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0089/2012
|
| PIP number |
EMEA-000917-PIP02-11
|
| Pharmaceutical form(s) |
Cutaneous solution
|
| Condition(s) / indication(s) |
Treatment of androgenic alopecia
|
| Route(s) of administration |
Cutaneous use
|
| Contact for public enquiries |
Allergan Pharmaceuticals International Limited
E-mail: ml-eu_reg_affairs@allergan.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|